These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30028775)

  • 1. Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
    Islam MM; Poly TN; Walther BA; Dubey NK; Anggraini Ningrum DN; Shabbir SA; Jack Li YC
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1395-1405. PubMed ID: 30028775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C; Wilhelm SM; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors therapy and risk of hip fracture: a systematic review and meta-analysis.
    Ye X; Liu H; Wu C; Qin Y; Zang J; Gao Q; Zhang X; He J
    Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):794-800. PubMed ID: 21701389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
    Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
    Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.
    Eom CS; Jeon CY; Lim JW; Cho EG; Park SM; Lee KS
    CMAJ; 2011 Feb; 183(3):310-9. PubMed ID: 21173070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Zhou B; Huang Y; Li H; Sun W; Liu J
    Osteoporos Int; 2016 Jan; 27(1):339-47. PubMed ID: 26462494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
    Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
    BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.
    Zirk-Sadowski J; Masoli JA; Delgado J; Hamilton W; Strain WD; Henley W; Melzer D; Ble A
    J Am Geriatr Soc; 2018 Jul; 66(7):1332-1338. PubMed ID: 29676433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
    Ma T; Wu M; Jia S; Yang L
    Int J Colorectal Dis; 2020 Dec; 35(12):2157-2169. PubMed ID: 32808072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.
    Abramowitz J; Thakkar P; Isa A; Truong A; Park C; Rosenfeld RM
    Otolaryngol Head Neck Surg; 2016 Oct; 155(4):547-54. PubMed ID: 27188706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.
    Eom CS; Park SM; Myung SK; Yun JM; Ahn JS
    Ann Fam Med; 2011; 9(3):257-67. PubMed ID: 21555754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors' use and risk of hip fracture: a systematic review and meta-analysis.
    Hussain S; Siddiqui AN; Habib A; Hussain MS; Najmi AK
    Rheumatol Int; 2018 Nov; 38(11):1999-2014. PubMed ID: 30159775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.
    Filion KB; Chateau D; Targownik LE; Gershon A; Durand M; Tamim H; Teare GF; Ravani P; Ernst P; Dormuth CR;
    Gut; 2014 Apr; 63(4):552-8. PubMed ID: 23856153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
    Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies.
    Wang CH; Li CH; Hsieh R; Fan CY; Hsu TC; Chang WC; Hsu WT; Lin YY; Lee CC
    Expert Opin Drug Saf; 2019 Mar; 18(3):163-172. PubMed ID: 30704306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors: bacterial pneumonia.
    Prescrire Int; 2012 Sep; 21(130):210-2. PubMed ID: 23016253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
    Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
    PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perils and pitfalls of long-term effects of proton pump inhibitors.
    Wilhelm SM; Rjater RG; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
    Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
    Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.